GTBP
GT Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.69
−4.84%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.39x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.24x
Liquidity & coverage
- Current ratio
- 2.61x
- Quick ratio
- 2.61x
- Cash ratio
- 2.24x
- Interest coverage
- -128.64x
- EBITDA / interest
- -160.04x
- Working capital
- $3.6M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026